{"denoms":[{"counts":[{"groupId":"BG000","value":"68"},{"groupId":"BG001","value":"143"},{"groupId":"BG002","value":"211"}],"units":"Participants"}],"groups":[{"description":"Participants received matching placebo to venetoclax orally once a day (QD) plus cytarabine 20 mg/m² subcutaneously on Days 1 to 10 of each 28-day cycle.","id":"BG000","title":"Placebo + Low Dose Cytarabine (LDAC)"},{"description":"Participants received venetoclax 600 mg orally once a day plus cytarabine 20 mg/m² subcutaneously on Days 1 to 10 of each 28-day cycle.","id":"BG001","title":"Venetoclax + Low Dose Cytarabine (LDAC)"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"41.0","upperLimit":"88.0","value":"76.0"},{"groupId":"BG001","lowerLimit":"36.0","upperLimit":"93.0","value":"76.0"},{"groupId":"BG002","lowerLimit":"36.0","upperLimit":"93.0","value":"76.0"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"20"}],"title":"18 to < 65 years"},{"measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"50"},{"groupId":"BG002","value":"69"}],"title":"65 to < 75 years"},{"measurements":[{"groupId":"BG000","value":"40"},{"groupId":"BG001","value":"82"},{"groupId":"BG002","value":"122"}],"title":"≥ 75 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"29"},{"groupId":"BG001","value":"65"},{"groupId":"BG002","value":"94"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"39"},{"groupId":"BG001","value":"78"},{"groupId":"BG002","value":"117"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"47"},{"groupId":"BG001","value":"102"},{"groupId":"BG002","value":"149"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"39"},{"groupId":"BG002","value":"59"}],"title":"Asian"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"19"}],"title":"United States"},{"measurements":[{"groupId":"BG000","value":"26"},{"groupId":"BG001","value":"56"},{"groupId":"BG002","value":"82"}],"title":"European Union"},{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"15"}],"title":"China"},{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"27"}],"title":"Japan"},{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"47"},{"groupId":"BG002","value":"68"}],"title":"Rest of World"}]}],"description":"Rest of World includes Australia, Brazil, Canada, New Zealand, Puerto Rico, Russia, South Africa, South Korea, and Taiwan.","paramType":"COUNT_OF_PARTICIPANTS","title":"Region","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"45"},{"groupId":"BG001","value":"85"},{"groupId":"BG002","value":"130"}],"title":"De novo"},{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"58"},{"groupId":"BG002","value":"81"}],"title":"Secondary"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"AML Status","unitOfMeasure":"Participants"}]}